Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapse
Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), E. Condé(University of Bern), Juan Carlos García‐Ruiz, Jorge Sierra(Universitat Autònoma de Barcelona), M. Pascual, Enric Carreras(Josep Carreras Leukaemia Research Institute), J. Rifón(Clinica Universidad de Navarra), Juan Besalduch(Hospital Universitario Son Dureta), Isidro Jarque(Hospital Universitari i Politècnic La Fe), Álvaro Marchán-López(Hospital de Sant Pau), José M. Moraleda(Centro Regional de Hemodonación), A Iriondo(Hospital de Sant Pau), María‐Jesús Vidal, J. Marín, José García‐Laraña, Carmen Albó(Spanish National Centre for Cardiovascular Research), Marı́a Dolores Caballero(Complejo Hospitalario de Salamanca), J M Fernández-Rañada(Hospital Universitario de La Princesa), J Petit, J Díaz-Mediavilla(Hospital de Sant Pau), M. Constans(Hospital de Sant Pau), M.V. Mateos(Hospital de Sant Pau), Pilar Rioja Torres(Hospital de Sant Pau), R. Arranz(Hospital Universitario de La Princesa), D. Carrera(Hospital de Sant Pau), Katy Perez‐Equiza, J Garcı́a-Conde(Hospital de Sant Pau), A. Torres(Outcomes Research Consortium), R Cabrera(Hospital de Sant Pau), Juan José Lahuerta(Research Institute Hospital 12 de Octubre)
Cited by 220
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k